Hepatology Drugs
46 FDA-approved drugs
TheraRadar tracks 46 FDA-approved hepatology drugs from 31 companies across 8 drug classes, led by Teva, with 120 active clinical trials in the pipeline. Explore recent approvals, top companies, active trials by indication, and drug classes for Hepatology.
Hepatology Approvals by Year
2
'15
4
'16
1
'17
3
'18
2
'19
'20
2
'21
'22
1
'23
3
'24
1
'25
'26
Recent Hepatology Drug Approvals
DOPTELET SPRINKLE
AVATROMBOPAG MALEATE
thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedu...
2025-07-24
AKARX INC
TPO receptor
LIVDELZI
SELADELPAR LYSINE
primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults who have...
2024-08-14
Gilead Sciences
CYP7A1PPARδ
IQIRVO
ELAFIBRANOR
primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults who have...
2024-06-10
IPSEN
PPAR-alphaPPAR-deltaPPAR-gamma
REZDIFFRA
RESMETIROM
REZDIFFRA is indicated in conjunction with diet and exercise for the treatment of adults with noncir...
2024-03-14
MADRIGAL
OBETICHOLIC ACID
OBETICHOLIC ACID
2023-05-30
OPTIMUS PHARMA PRIVATE LTD
LIVMARLI
MARALIXIBAT CHLORIDE
cholestatic pruritus in patients 3 months of age and older with Alagille syndrome (ALGS)...
2021-09-29
MIRUM
IBAT
BYLVAY
ODEVIXIBAT
pruritus in patients 3 months of age and older with PFIC...
2021-07-20
IPSEN
IBAT
NOURESS
CYSTEINE HYDROCHLORIDE
2019-12-13
Baxter
ELCYS
CYSTEINE HYDROCHLORIDE
use as an additive to amino acid solutions to meet the nutritional requirements of newborn infants r...
2019-04-16
EXELA PHARMA
Cystathionase
MULPLETA
LUSUTROMBOPAG
thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedu...
2018-07-31
VANCOCIN ITALIA
TPO receptor
OMEGAVEN
FISH OIL TRIGLYCERIDES
the prevention of PNAC...
2018-07-27
Fresenius Kabi
DOPTELET
AVATROMBOPAG MALEATE
thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedu...
2018-05-21
AKARX INC
TPO receptor
JADENU SPRINKLE
DEFERASIROX
chronic iron overload due to blood transfusions in patients 2 years of age and older...
2017-05-18
Novartis
Iron
SMOFLIPID 20%
FISH OIL
SMOFlipid is indicated in adult and pediatric patients, including term and preterm neonates, as a so...
2016-07-13
Fresenius Kabi
OCALIVA
OBETICHOLIC ACID
2016-05-27
INTERCEPT
DEFITELIO
DEFIBROTIDE SODIUM
adult and pediatric patients with hepatic veno-occlusive disease (VOD), also known as sinusoidal obs...
2016-03-30
JAZZ PHARMS
Plasmin
CETYLEV
ACETYLCYSTEINE
2016-01-29
ARBOR PHARMS LLC
JADENU
DEFERASIROX
chronic iron overload due to blood transfusions in patients 2 years of age and older...
2015-03-30
Novartis
Iron
CHOLBAM
CHOLIC ACID
bile acid synthesis disorders due to single enzyme defects (SEDs)...
2015-03-17
MIRUM
FXR
EOVIST
GADOXETATE DISODIUM
use in magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adult and...
2008-07-03
Bayer
Showing the 20 most recent of 46 hepatology drugs. View all 46 →
Top Hepatology Companies
Hepatology Active Trials by Indication
120 active trials — the forward pipeline, not just approvals.
All competitive landscapes →Hepatology Drug Classes
Iron Chelator 3
Antidote 2
Osmotic Laxative 2
Peroxisome Proliferator-activated Receptor Agonist 1
Thyroid Hormone Receptor beta Agonist 1
Ileal Bile Acid Transporter Inhibitor 1
Lipid Emulsion 1
Bile Acid 1
Hepatology at a Glance
- Total Drugs
- 46
- Companies
- 31
- Drug Classes
- 8
- Active Trials
- 120
- Latest Approval
- 2025-07-24